FDA inspection
Pharmacreams Corporation: FDA inspection ending Aug 21, 2007
FDA inspection 480933 · Voluntary Action Indicated (VAI) · Medley, FL
Key facts
| Inspection ID | 480933 |
|---|---|
| Firm | Pharmacreams Corporation |
| FEI number | 3004541289 |
| Address | 8314 NW South River Dr |
| City | Medley |
| State | FL |
| ZIP | 33166-7422 |
| Fiscal year | 2007 |
| Inspection end date | Aug 21, 2007 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs |
| Product type | Drugs, Food/Cosmetics |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data